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Abstract The dependence of CMP-N-acetylneuraminate:GMl 
sialyltransferase (SAT IV) activity of rat liver Golgi apparatus 
on GM1 ganglioside ceramide composition was evaluated. SAT 
IV activity was assayed on GMI molecular species carrying 
homogeneous ceramide moieties containing long chain bases of 
different length (18 or 20 C atoms) unsaturated or not, linked to 
14:0, 16:0, 18:0 or 22:0 fatty acids. The results obtained in the 
presence of the detergent Triton CF-54, when enzyme and 
substrate are presumably part of the same supramolecular 
structure, show that either the long chain base or the fatty acid 
composition can affect enzyme activity. This feature was not 
displayed when GM1 was embedded in dipalmitoylphosphatidyl- 
choline vesicles in the absence of detergent. Under the latter 
conditions, the enzyme was not sensitive to the lipid composition 
of GMI but to the gangliosidelphospholipid ratio in the vesicles. 
These results indicate for the first time that SAT IV is affected 
by the lipid composition of the substrate and strengthen the 
hypothesis that glycosyltransferases may contribute to control 
the cellular glycosphingolipid ceramide pattern. 
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[6,7]. Moreover, it has been shown that glycosyltransferases 
are able to recognize different molecular species of the sub- 
strate, providing a mechanism aiming to maintain the glyco- 
lipid ceramide pattern of a given tissue [8]. The present work 
was carried out in order to assess whether SAT IV differen- 
tially affects molecular species of the same substrate, namely 
GM1 ganglioside, carrying different, homogeneous, ceramide 
moieties. 
2. Materials and methods 
2.1. Materials' 
Commercial chemicals were of the highest purity available. Solvents 
were redistilled before use. HPTLC plates, sucrose for density gradi- 
ent centrifugation a d common chemicals were from Merck (Darm- 
stadt, Germany). Cytidine 5'-monophospho-N-acetylneuraminic cid 
(CMP-Neu5Ac), Triton CF-54, mucin, asialofetuin and fatty acid an- 
hydrides were obtained from Sigma Chemical Co. (St. Louis, MO, 
USA). Dipalmitoylphosphatidylcholine (DPPC) was from Fluka AG 
(Buchs, Switzerland). CMP-[9-3H]Neu5Ac (21.2 Ci/mmol) was from 
Du Pont New England Nuclear (NEN) (Boston, MA, USA). NaB3H4 
(5 Ci/mmol) and UDP-[U-laC]galactose (340 mCi/mmol) were from 
Amersham International (Amersham, UK). 
I Introduction 
It is known that gangliosides differ in the chemical compo- 
sition of their oligosaccharide and lipid moieties. In fact, long 
c!min bases (LCB) and fatty acids, ceramide components, may 
~Lry in both length and unsaturation, yielding several molec- 
uiar species [1,2]. Remarkable differences in the lipid compo- 
sition are observed in extraneural tissues, including liver [3], 
a id,  for a given tissue, also between gangliosides deriving 
flom distinct biosynthetic pathways (e.g. the so-called 'a' 
a ad 'b' series) [2]. Ganglioside biosynthesis proceeds through 
the sequential transfer of monosaccharide units from sugar 
n acleotide donors to appropriate sphingolipid acceptors, cat- 
aiyzed by specific glycosyltransferases [4]. Most of these 
e~zymes, and among them rat liver CMP-N-acetylneur- 
aminate:GMa sialyltransferase (SAT IV), have been localized 
v ithin the Golgi apparatus and have been shown to be inte- 
ua l  membrane proteins [5]. Previous findings suggest that the 
~.anglioside pattern may be regulated, at least in part, at the 
l~vel of sialyltransferase activities. Accordingly, the differential 
e ~pression of glycosyltransferases is very likely a major factor 
cietermining the distinct cell glycosphingolipid pattern encoun- 
tered at different stages of growth, development and oncogeny 
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2.2. Preparation and radiolabeling of ganglioside molecular species 
GM1 ganglioside molecular species were prepared following essen- 
tially a procedure already described [9], with minor modifications. 
Briefly, lyso-GM1 homogeneous in the saccharide portion but not in 
the lipid moiety was prepared starting from GM1 extracted and pur- 
ified from beef brain (native GM1) [10]. GM1 homogeneous in the 
fatty acid moiety, but not in LCB, was obtained from lyso-GM1 by 
reaction with fatty acid anhydrides (14:0, 16:0, 18:0 and 22:0) and 
purified by silica gel column chromatography. Further separation i to 
GM1 molecular species having homogeneous LCB (C 18:1 or C20:1) 
moiety was performed by reverse-phase HPLC [9]. Seven GM1 mole- 
cular species were obtained and used for SAT IV activity assays: 
C18:1 14:0, C18:1-16:0, C18:1-18:0, C18:1~2:0, C18:0-18:0, 
C20:1-18:0 and C20:0-18:0. GM1 molecular species C18:1-18:0, 
C20:1-18:0, radiolabeled at the level of C-3 of the LCB, were pre- 
pared as described [11]. The specific radioactivity was 1.3 Ci/mmol. 
Standard GDI~ ganglioside was obtained and radiolabeled as pre- 
viously described [12]. The final purity of all gangliosides was over 
99%. 
2.3. Preparation of vesicles containing GM1 
Mixtures of DPPC and GMI, dried and lyophilized from chloro- 
form/methanol (2:l, v/v) solutions, were resuspended in 154 mM ca- 
codylate buffer, pH 6.5, and vesicles prepared by extrusion (10 times) 
through 100 nm pore filters (Nucleopore, Pleasanton, CA, USA), 
using an N2 pressure-operated xtruder (Lipoprep, Ottawa, Canada). 
Vesicles were used within 1 day from the preparation for SAT IV 
assay. GM1 concentrations were calculated assuming that glycolipid 
molecules were equally partitioned into the outer and inner layer of 
the vesicles and therefore only 50% of total GM1 was accessible to the 
enzyme [13]. 
l~bbreviations: DPPC, dipalmitoylphosphatidylcholine; CMP- 
Neu5Ac, cytidine 5'-monophospho-N-acetylneuraminic acid; LCB, 
1,~ng chain base; SAT IV, CMP-N-acetylneuramfnate:GM1 sialyl- 
t~ ansferase 
2.4. Preparation of rat liver Golgi membranes 
Liver Golgi membrane fractions were prepared from male Sprague- 
Dawley rats (Charles River, Milan, Italy) weighing 150-175 g, as 
already reported [14]. 
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2.5. Assay of SAT IV activity on GM1 ganglioside using CMP-[9- 
aH]Neu5Ac 
SAT IV activity was routinely assayed upon GM~ ganglioside ac- 
cording to a widely used procedure [15-17], by radiochemical quanti- 
fication of the product (GDla ganglioside). Briefly, incubation mix- 
tures contained 0.2% Triton CF-54, 20-30 Bg of the Golgi fraction (as 
protein), 0.0254).4 mM GM1 and 0.5 mM CMP-[9-3H]Neu5Ac 
(100000 dpm) as sialic acid acceptor and donor, respectively, in a 
final volume of 50 B1 of 154 mM cacodylate buffer, pH 6.5. Incuba- 
tion was at 37°C for 1 h. Blanks were prepared by omitting GM~ in 
the reaction mixture. At the end of the incubation, the reaction mix- 
ture was applied on Whatman 3MM paper and developed by descend- 
ing chromatography in 1% tetraborate, followed by radioactivity 
counting of the appropriate areas [15]. 
SAT IV activity was also assayed on GM~ embedded in DPPC 
vesicles. In this case, a mixture was prepared in the absence of deter- 
gent and contained 0.025q).25 mM GM1 in vesicles, 20-30 txg (as 
proteins) of Golgi fraction (previously sonicated in a bath for a few 
seconds [18]), in a final volume of 50 lal of 154 mM cacodylate buffer 
pH 6.5. CMP-[9-aH]Neu5Ac (0.5 mM, 100000 dpm) was added and 
the mixture was incubated at 37°C for 1 h. At the end of the incuba- 
tion the whole reaction mixture was processed as above. Drying of the 
sample loaded on chromatographic paper before descending chroma- 
tography prevented separation of radiolabeled CMP-Neu5Ac from 
newly synthesized radiolabeled GDla, and therefore it was avoided. 
Reaction product characterization was performed as already described 
[16]. 
2.6. Assay of SAT IV activity using radiolabeled GM1 
Reaction mixtures almost identical to those described above were 
prepared with the only modification that radiolabeled GM1 (100000 
dpm, corresponding to about 38 pmol) was added besides unlabeled 
GM1, and that unlabeled CMP-Neu5Ac was used [19]. Blank mix- 
tures were prepared using an heat-inactivated nzyme source. After 
incubation the samples were submitted to lipid extraction by adding 
4 vols. of tetrahydrofuran, vortexing and centrifuging (10000×g, 10 
min). Aliquots of the supernatant were chromatographed by HPTLC, 
(first run: chloroform/methanol/H20, 110:40:6; second run: chloro- 
form/methanol/CaClz 0.2%, 50:42:11 v/v) and scanned with a radio- 
chromatoscanner [20]. Reaction product characterization was per- 
formed as already described [16]. 
2. 7. Other methods 
The kinetic parameters Km and Vm~x were determined from the 
double-reciprocal plot according to Lineweaver-Burk, by linear re- 
gression [21]. Golgi markers enzymes, CMP-Neu5Ac:asialofetuin sia- 
lyltransferase and UDP-Gahasialomucin galactosyltransferase w re 
assayed according to [22] and [23]. Gangliosides were determined as 
bound Neu5Ac [24], using Neu5Ac as standard; proteins [25] using 
bovine serum albumin as the standard. 
3. Results and discussion 
Many studies dealt with the specificity of sialyltransferases 
towards the oligosaccharide moiety of their glycolipid sub- 
strates. In particular, it is known that rat liver CMP-N-acet- 
ylneuraminate:GM1 sialyltransferase (SAT IV), an enzyme 
localized in the Golgi apparatus, is able to catalyze the syn- 
thesis of GM3, (3Mlb, GDla, and GTlb gangliosides [26]. In 
contrast, the specificity of sialyltransferases towards molecular 
species of the same substrate, carrying different ceramide moi- 
eties, has not yet been fully investigated. Remarkably, existing 
reports indicate that the chemical composition of the ceramide 
portion can affect the enzyme activity [27,28]. 
In the present study, for the first time, the GDla-synthetase 
activity of SAT IV was studied on a number of GM1 gang- 
lioside molecular species, differing in either LCB or fatty acid 
composition, generally representative of the variability nor- 
mally encountered in vivo [2,3]. The enzyme source used for 
the study of SAT IV activity was a highly purified Golgi 
apparatus fraction prepared from rat liver. The assay of Golgi 
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marker enzymes CMP-Neu5Ac:asialofetuin sialyltransferase 
and UDP-Gal:asialo-mucin galactosyltransferase showed an 
enrichment over 60-and 75-fold, respectively. 
One of the problems encountered in studying lycosyltrans- 
ferases is introducing exogenous substrates into the membrane 
where the enzyme is located. Traditionally, this is accom- 
plished by dispersing the substrate with detergents 
[18,29,30]. For this reason, the enzyme activity was assayed 
in the presence of Triton CF-54 [15] and labeled CMP- 
Neu5Ac. Four GM1 molecular species carrying the same 
C18:1 LCB moiety and acyl chains of different length were 
tested. The results are reported in Fig. 1 and in Table 1. The 
data suggest hat the kinetics is not markedly affected by fatty 
acid length, in the range between 14 and 18 C atoms. A sig- 
nificantly different behavior is displayed upon the molecular 
species carrying 22:0 acyl chains, the value of the apparent 
Vm~ and Km for this latter species (56 and 0.15, respectively) 
being about 1/3-1/4 with respect o the others. 
Subsequently, SAT IV activity was assayed on four GM1 
molecular species carrying the same fatty acyl moiety (18:0) 
and different LCB. The results are reported in Fig. 1. On 
increasing the substrate concentration, V increases displaying 
an apparently classical behavior, from which Vmax and Km can 
be calculated (Table 1). Marked inhibition is recorded with 
C20 LCB species at substrate concentrations above Kin, as has 
also been observed for other glycosyltransferases [31,32]. Also, 
the C18 species demonstrated the inhibition phenomenon, but 
at higher concentration (about 0.4 mM, data not shown). Due 
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Fig. 1. Substrate dependence of SAT IV activity on GM1 ganglio- 
side ceramide composition. Data shown are the mean of three ex- 
periments. Bars indicate the S.D. values. (A) Molecular species car- 
rying C18:1 long chain base and 14:0 (zx), 16:0 ([2), 18:0 (O) or 
22:0 (A), fatty acid. (Inset) Lineweaver-Burk reciprocal plot of the 
same data. (B) Molecular species carrying 18:0 fatty acid and C18:0 
(©), C18:1 (O), C20:0 (O) or C20:I (0) long chain base. (Inset) 
Lineweaver-Burk reciprocal plot of the same data. 
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Table 1 
Kinetic parameters of SAT IV activity on GM1 molecular species in the presence ofdetergent or %mbedded inphospholipid vesicles, in the ab- 
sence of detergent 
GM1 molecular species Vm~ (nmol/h per mg protein) Km (mM) 
(k)ng chain base/fatty acid) 
Ci8:1/14:0 123 0.41 
C 8:1/16:0 136 0.47 
C 8:1/18:0 120 0.33 
C 8:1/22:0 56 0.15 
C 8:0/18:0 130 0.29 
C.'O:1/18:0 191 0.19 
C :0:0/18:0 196 0.21 
C 8:1/18:0 ~ 10.7 0.ll 
C '.0:1/18:0 ~ 9.9 0.12 
Tie kinetic parameters are related to GMI ganglioside. Vm~x and Km values were calculated from insets of Figs. 1 and 2 by linear regression; 
t~ ~ correlation coefficients (c) were 0.999>c>0.992. 
t( these reasons, the relative activity upon the different mo- 
le:ular species depended on the actual substrate concentra- 
ti,)n. At low concentration, at which the inhibition was not 
y~.t apparent, the longer molecular species C20 LCB were 
preferentially selected with respect o the shorter C18 ones, 
irrespective of whether or not unsaturation was present. In 
c,,ntrast, at higher substrate concentration the enzyme had 
lets effect on GM1 containing C20 LCB, due to the earlier 
st bstrate inhibition encountered with these species. These re- 
s~Jts were also confirmed by the assay performed in the pre- 
sence of GM1 molecular species C18:1-18:0, C20:1-18:0, 
r~diolabeled at the level of C-3 of the LCB (data not shown). 
"I tken together, these results suggest hat SAT IV activity is 
affected by the lipid composition of the substrate, GM1 gang- 
lioside. As has already been discussed [27], and not completely 
c}arified, various reasons could explain this striking feature. 
One of these hypotheses i  that insertion into the same mem- 
b:ane is a prerequisite for the enzyme to recognize molecular 
species [29,30]. To test this possibility, SAT IV was assayed on 
labeled GM1 molecular species carrying the same fatty acid 
moiety (18:0) and different LCBs (C18:1,C20:1) embedded in 
phospholipid vesicles, in the absence of detergents. For these 
experiments an enzyme preparation previously sonicated was 
used, as suggested [18], in order to expose the catalytic do- 
main of the enzyme. Accordingly, the activity of non-soni- 
cared enzyme preparations was undetectable in the absence 
of detergents. Moreover, sonication did not alter the enzyme 
activity, assayed in the presence of detergent. Two observa- 
tions are worth mentioning, on comparing the results shown 
in Fig. 2 with those obtained in the presence of the detergent 
and reported in Fig. 1. First, at a given substrate concentra- 
tion the activity is much lower and, second, the activity is not 
apparently affected by the LCB composition of the substrate 
present in a liposomal dispersion. The same results were ob- 
tained using cold GM1 and labeled CMP-Neu5Ac (data not 
shown). Therefore, the dependence of enzyme activity upon 
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F~g. 2. Substrate dependence of SAT IV activity on GMI ganglioside molecular species (carrying 18:0 fatty acid) embedded indipalmitoylphos- 
phatidylcholine v sicles. Data shown are the mean of three experiments. Bars indicate the S.D. values. (A) Dependence on the concentration f
species carrying C18:l long chain base (O) or C20:l long chain base (0). Ganglioside/phospholipid molar ratio was 21% for all experiments. 
(Inset) Lineweaver-Burk reciprocal plot of the same data. (B) SAT IV activity dependence onthe % (ganglioside/phospholipid molar ratio) of 
GM1 species carrying C18:l long chain base mbedded in the vesicles. 
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GMI ceramide is observed only when the enzyme and the 
substrate are added to the incubation mixture in the presence 
of detergents, and are presumably part of the same supramo- 
lecular structures. These results suggest he possibility of a 
direct recognition of the acceptor lipid moiety by the trans- 
membrane domain of the enzyme, as hypothesized for CMP- 
N-acetylneuraminate:lactosylceramide sialyltransferase [27]. 
The dependence of the enzyme activity on the GM1/phospho- 
lipid ratio was also investigated using the C18:1/18:0 species. 
The results, reported in Fig. 2, show that the substrate density 
within the vesicles affects SAT IV activity, which increases 
together with the percentage of GM1 in the bilayer. These 
results suggest hat the different segregation properties dis- 
played by ganglioside molecular species [33,34] may be impor- 
tant in modulating the enzymatic activity. Moreover, the seg- 
regation of gangliosides is known to be affected by the 
difference between their lipid composition and that of sur- 
rounding phospholipids [33]. Thus, the molecular species pe- 
cificity of SAT IV, as already suggested for CMP-N-acetyl- 
neuraminate:lactosylceramide sialyltransferase [8] could 
depend on the phospholipid molecular species composition 
of the membranous microenvironment of the enzyme. 
In conclusion, these results indicate for the first time that 
SAT IV, as other glycosyltransferases, is ensitive to the lipid 
moiety composition of the substrate and strengthen the hy- 
pothesis of the presence of a ceramide-modulated, glycosyl- 
transferase-driven glycosphingolipid biosynthesis. 
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